A green, low-cost carbon dot nanoparticle platform designed to overcome the bottleneck of biomolecule delivery into intact plant cells. Enables transient gene expression, spray-on gene editing, RNAi, and pathogen protection, offering a versatile tool for accelerating plant biotechnology research and crop improvement.
This solution addresses one of the most persistent bottlenecks in plant biotechnology: delivering nucleic acids and other biomolecules into intact plant cells. The platform uses carbon dot nanoparticles complexed with nucleic acids to enable universal plant uptake and efficient cargo release. By offering a simple, inexpensive, and green formulation, it removes the cost and purification barriers that have limited broader adoption of nanoparticle-based delivery in plants.
The technology supports a wide range of applications, including transient gene expression studies, spray-on gene editing, RNAi-based pathogen protection, and accelerated validation of genetic elements on transcription and translation. Its versatility makes it valuable for academic research, agricultural biotechnology companies, and crop improvement programs seeking faster, higher signal-to-noise alternatives to conventional plant transformation platforms.
Key features:
Targeted applications:
The platform is currently at an early-to-mid stage of development. Proof-of-concept has been established through leaf infiltration experiments demonstrating fluorescent gene expression confirmed by microscopy. A rapid, high-throughput transient expression system is being established to evaluate large numbers of formulations in parallel, with over ten formulations already tested and additional candidates in the optimization pipeline.
Next-stage validation will focus on identifying functional carbon dot-nucleic acid complexes that achieve efficient delivery into intact plant cells, characterizing the chemical structure and material properties of the most promising formulations, and demonstrating functionality with reporter genes, genome editing tools, and plant protective genes. These steps will advance the platform toward broader translational use in plant biotechnology and crop improvement.
Penn State University is a comprehensive public land‑grant research university with a large multi‑campus footprint across Pennsylvania. Industry engages through a research and technology park adjacent to the flagship campus that houses corporate R&D, co‑located labs, and flexible collaboration space, as well as a statewide extension network that enables field testing, demonstration, and workforce reach. Integration with a major hospital system supports clinical translation, and an applied research laboratory fosters mission‑driven partnerships with government and industry sponsors. Research is supported by competitive federal funding from agencies such as NSF, NIH, DOE, USDA, DoD, and NASA. A dedicated technology transfer office manages IP, licensing, and startup formation to accelerate commercialization.